Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Details for Australian Patent Application No. 2009231967 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Goble, Stephen D.; Harper, Bart; Kopka, Ihor E.; Shen, Dong-ming; Edmondson, Scott D.; Berger, Richard; Morriello, Gregori J.; Moyes, Chris R.; Kar, Nam Fung; Li, Bing; Wendt, Harvey; Zhu, Cheng; Chang, Lehua; Wang, Liping

Agent Spruson & Ferguson

Pub. Number AU-A-2009231967

PCT Pub. Number WO2009/123870

Priority 61/123,062 04.04.08 US

Filing date 23 March 2009

Wipo publication date 8 October 2009

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/123870 Priority application(s): WO2009/123870

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231978-Purine derivatives as A3 receptorselective agonists

2009231960-Dynamic frequency scaling of a switched mode power supply